21-33914467-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000290299.7(ATP5PO):āc.70T>Cā(p.Phe24Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,613,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000290299.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP5PO | NM_001697.3 | c.70T>C | p.Phe24Leu | missense_variant | 2/7 | ENST00000290299.7 | NP_001688.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP5PO | ENST00000290299.7 | c.70T>C | p.Phe24Leu | missense_variant | 2/7 | 1 | NM_001697.3 | ENSP00000290299.2 | ||
ENSG00000249209 | ENST00000429238.2 | c.70T>C | p.Phe24Leu | missense_variant | 3/8 | 5 | ENSP00000394107.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000879 AC: 22AN: 250334Hom.: 0 AF XY: 0.0000960 AC XY: 13AN XY: 135374
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1460854Hom.: 0 Cov.: 30 AF XY: 0.0000413 AC XY: 30AN XY: 726682
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2023 | The c.70T>C (p.F24L) alteration is located in exon 2 (coding exon 2) of the ATP5O gene. This alteration results from a T to C substitution at nucleotide position 70, causing the phenylalanine (F) at amino acid position 24 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at